Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

EGFR Peptide (human, mouse) (myristoylated) TFA

😃Good
Catalog No. T83692
Alias N-myristoyl-RKRTLRRL, Myr-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH, Epidermal Growth Factor Receptor Peptide

EGFR peptide (myristoylated), a synthetic peptide inhibitor of PKC (IC50 = 5 µM), corresponds to the intracellular region's amino acid sequence of EGFR. It effectively reverses doxorubicin resistance in UV-2237M (UV-2237M-ADRR) fibrosarcoma cells at a concentration of 1 µM.

EGFR Peptide (human, mouse) (myristoylated) TFA

EGFR Peptide (human, mouse) (myristoylated) TFA

😃Good
Catalog No. T83692Alias N-myristoyl-RKRTLRRL, Myr-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH, Epidermal Growth Factor Receptor Peptide
EGFR peptide (myristoylated), a synthetic peptide inhibitor of PKC (IC50 = 5 µM), corresponds to the intracellular region's amino acid sequence of EGFR. It effectively reverses doxorubicin resistance in UV-2237M (UV-2237M-ADRR) fibrosarcoma cells at a concentration of 1 µM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$105InquiryInquiry
10 mg$196InquiryInquiry
50 mg$790InquiryInquiry
100 mg$1,260InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
EGFR peptide (myristoylated), a synthetic peptide inhibitor of PKC (IC50 = 5 µM), corresponds to the intracellular region's amino acid sequence of EGFR. It effectively reverses doxorubicin resistance in UV-2237M (UV-2237M-ADRR) fibrosarcoma cells at a concentration of 1 µM.
SynonymsN-myristoyl-RKRTLRRL, Myr-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH, Epidermal Growth Factor Receptor Peptide
Chemical Properties
Molecular Weight1308.71
FormulaC60H117N21O11.XCF3COOH
SmilesCC(C)C[C@@H](C(O)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@H]([C@H](O)C)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC(CCCCCCCCCCCCC)=O)=O)=O)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
SequenceAc-Tyr(PO3H2)-xiIle-Asn-Gln-Ser-Val-NH2
Sequence ShortXXNQSV
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
PBS pH 7.2: 2 mg/mL (1.53 mM), Sonication is recommended.
DMSO: 10 mg/mL (7.64 mM), Sonication is recommended.
DMF: 10 mg/mL (7.64 mM), Sonication is recommended.
Solution Preparation Table
PBS pH 7.2/DMSO/DMF
1mg5mg10mg50mg
1 mM0.7641 mL3.8206 mL7.6411 mL38.2056 mL
DMSO/DMF
1mg5mg10mg50mg
5 mM0.1528 mL0.7641 mL1.5282 mL7.6411 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy EGFR Peptide (human, mouse) (myristoylated) TFA | purchase EGFR Peptide (human, mouse) (myristoylated) TFA | EGFR Peptide (human, mouse) (myristoylated) TFA cost | order EGFR Peptide (human, mouse) (myristoylated) TFA | EGFR Peptide (human, mouse) (myristoylated) TFA chemical structure | EGFR Peptide (human, mouse) (myristoylated) TFA formula | EGFR Peptide (human, mouse) (myristoylated) TFA molecular weight